Moreover, while a defective differentiation and functional alteration of the endogenous DC has been observed in cancer patients [46], our results indicate that the generation of autologous IFN-DC ex vivo may potentially circumvent tumor-induced dysfunction in antigen-presenting cells. This evidence concerns the gene IFNA1 and cancer.